Jonathan Stuart Kaplan
Examiner (ID: 15168)
Most Active Art Unit | 2836 |
Art Unit(s) | 2107, 2104, 2836 |
Total Applications | 226 |
Issued Applications | 203 |
Pending Applications | 10 |
Abandoned Applications | 13 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5131149
[patent_doc_number] => 20070207546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'BOVINE IMMUNODEFICIENCY VIRUS (BIV) BASED VECTORS'
[patent_app_type] => utility
[patent_app_number] => 11/610865
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17433
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207546.pdf
[firstpage_image] =>[orig_patent_app_number] => 11610865
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610865 | Bovine immunodeficiency virus (BIV) based vectors | Dec 13, 2006 | Issued |
Array
(
[id] => 5474568
[patent_doc_number] => 20090247734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Chemically Derivatized CD4 and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/086675
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 485
[patent_figures_cnt] => 485
[patent_no_of_words] => 31413
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12086675
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086675 | Chemically Derivatized CD4 and Uses Thereof | Dec 13, 2006 | Abandoned |
Array
(
[id] => 4785563
[patent_doc_number] => 20080138892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Hepadna virus core proteins as vaccine platforms and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/635271
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 41999
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11635271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/635271 | Hepadna virus core proteins as vaccine platforms and methods of use thereof | Dec 4, 2006 | Abandoned |
Array
(
[id] => 5183041
[patent_doc_number] => 20070054395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications'
[patent_app_type] => utility
[patent_app_number] => 11/599584
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 177
[patent_figures_cnt] => 177
[patent_no_of_words] => 40862
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11599584
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/599584 | Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications | Nov 12, 2006 | Abandoned |
Array
(
[id] => 5056834
[patent_doc_number] => 20070059756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies'
[patent_app_type] => utility
[patent_app_number] => 11/595628
[patent_app_country] => US
[patent_app_date] => 2006-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19809
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595628
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595628 | Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies | Nov 7, 2006 | Abandoned |
Array
(
[id] => 5336830
[patent_doc_number] => 20090053294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Anti Mineralocorticoid Therapy of Infection'
[patent_app_type] => utility
[patent_app_number] => 12/084312
[patent_app_country] => US
[patent_app_date] => 2006-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9620
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053294.pdf
[firstpage_image] =>[orig_patent_app_number] => 12084312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084312 | Anti Mineralocorticoid Therapy of Infection | Oct 30, 2006 | Abandoned |
Array
(
[id] => 4933442
[patent_doc_number] => 20080004217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'TREATMENT OF HIV-ASSOCIATED DYSMORPHIA/DYSMETABOLIC SYNDROME (HADDS) WITH OR WITHOUT LIPODYSTROPHY'
[patent_app_type] => utility
[patent_app_number] => 11/552753
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13913
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004217.pdf
[firstpage_image] =>[orig_patent_app_number] => 11552753
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/552753 | TREATMENT OF HIV-ASSOCIATED DYSMORPHIA/DYSMETABOLIC SYNDROME (HADDS) WITH OR WITHOUT LIPODYSTROPHY | Oct 24, 2006 | Abandoned |
Array
(
[id] => 5040588
[patent_doc_number] => 20070092870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Detection of biomolecules'
[patent_app_type] => utility
[patent_app_number] => 11/584072
[patent_app_country] => US
[patent_app_date] => 2006-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8779
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11584072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/584072 | Detection of biomolecules | Oct 19, 2006 | Abandoned |
Array
(
[id] => 6583700
[patent_doc_number] => 20100047763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Plasmid Expression Vectors for Expression of Recombinant Rotavirus and Astrovirus Proteins or Epitopes'
[patent_app_type] => utility
[patent_app_number] => 12/083910
[patent_app_country] => US
[patent_app_date] => 2006-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11224
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047763.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083910
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083910 | Plasmid Expression Vectors for Expression of Recombinant Rotavirus and Astrovirus Proteins or Epitopes | Oct 19, 2006 | Abandoned |
Array
(
[id] => 5253237
[patent_doc_number] => 20070134693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes'
[patent_app_type] => utility
[patent_app_number] => 11/584041
[patent_app_country] => US
[patent_app_date] => 2006-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6449
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11584041
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/584041 | Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes | Oct 19, 2006 | Abandoned |
Array
(
[id] => 5052091
[patent_doc_number] => 20070032636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Chimeric retroviral Gag genes and screening assays'
[patent_app_type] => utility
[patent_app_number] => 11/582744
[patent_app_country] => US
[patent_app_date] => 2006-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17636
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11582744
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/582744 | Chimeric retroviral Gag genes and screening assays | Oct 17, 2006 | Abandoned |
Array
(
[id] => 5473051
[patent_doc_number] => 20090246217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity'
[patent_app_type] => utility
[patent_app_number] => 12/083086
[patent_app_country] => US
[patent_app_date] => 2006-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18755
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083086 | Peptides for modulating innate immunity | Oct 3, 2006 | Issued |
Array
(
[id] => 5056877
[patent_doc_number] => 20070059799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions'
[patent_app_type] => utility
[patent_app_number] => 11/522314
[patent_app_country] => US
[patent_app_date] => 2006-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 76162
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059799.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522314 | Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions | Sep 17, 2006 | Abandoned |
Array
(
[id] => 7527593
[patent_doc_number] => 08044185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes'
[patent_app_type] => utility
[patent_app_number] => 12/065894
[patent_app_country] => US
[patent_app_date] => 2006-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 114133
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/044/08044185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065894
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065894 | Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes | Sep 5, 2006 | Issued |
Array
(
[id] => 33093
[patent_doc_number] => 07785888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Metabolically activated recombinant viral vectors and methods for their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 11/514820
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 21793
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785888.pdf
[firstpage_image] =>[orig_patent_app_number] => 11514820
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/514820 | Metabolically activated recombinant viral vectors and methods for their preparation and use | Aug 31, 2006 | Issued |
Array
(
[id] => 4994604
[patent_doc_number] => 20070009949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Paramyxovirus-derived RNP'
[patent_app_type] => utility
[patent_app_number] => 11/515341
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 95
[patent_no_of_words] => 43224
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11515341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/515341 | Paramyxovirus-derived RNP | Aug 31, 2006 | Abandoned |
Array
(
[id] => 5119965
[patent_doc_number] => 20070141679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Methods and compositions for the treatment and prevention of HIV infection using TRIM5alpha'
[patent_app_type] => utility
[patent_app_number] => 11/510500
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 48216
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11510500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/510500 | Methods and compositions for the treatment and prevention of HIV infection using TRIM5α | Aug 24, 2006 | Issued |
Array
(
[id] => 5171289
[patent_doc_number] => 20070071720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Method of treating hepatitis B viral infection'
[patent_app_type] => utility
[patent_app_number] => 11/500775
[patent_app_country] => US
[patent_app_date] => 2006-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2495
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20070071720.pdf
[firstpage_image] =>[orig_patent_app_number] => 11500775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/500775 | Method of treating hepatitis B viral infection | Aug 7, 2006 | Abandoned |
Array
(
[id] => 4532925
[patent_doc_number] => 07888102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => 'Cell line for producing coronaviruses'
[patent_app_type] => utility
[patent_app_number] => 11/988146
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6797
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/888/07888102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988146
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988146 | Cell line for producing coronaviruses | Jul 20, 2006 | Issued |
Array
(
[id] => 5834599
[patent_doc_number] => 20060246429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Dot-elisa for the detection of animal viruses'
[patent_app_type] => utility
[patent_app_number] => 11/480482
[patent_app_country] => US
[patent_app_date] => 2006-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6474
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11480482
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/480482 | Dot-elisa for the detection of animal viruses | Jul 4, 2006 | Abandoned |